Deferred Tax Assets, Valuation Allowance in USD of Journey Medical Corp from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Journey Medical Corp quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2021 to Q4 2024.
  • Journey Medical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $24M, a 19.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Journey Medical Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $24M +$3.89M +19.3% 31 Dec 2024 10-K 27 Mar 2025
Q4 2023 $20.2M +$847K +4.39% 31 Dec 2023 10-K 27 Mar 2025
Q4 2022 $19.3M +$8.44M +77.6% 31 Dec 2022 10-K 29 Mar 2024
Q4 2021 $10.9M 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.